Drugs / Diane-35
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT03264638 | Oct 2016 → Aug 2018 | polycystic ovary syndrome | Aijun Sun | Unknown | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT05316935 | Jul 2022 → Mar 2026 overdue | atypical endometrial hyperplasia, endometrium neoplasm, progesterone resistance | Xiaojun Chen | Recruiting | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT01752270 | Dec 2012 → Dec 2013 | polycystic ovary syndrome | First Affiliated Hospital, Sun Yat-Sen University | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03151005 Comparator | Jul 2017 → Apr 2021 | obesity disorder, polycystic ovary syndrome | Xinqiao Hospital of Chongqing | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Diane-35 | “metformin with Diane 35 oral intake.” NCT03151005 ↗ |
| Route | Oral | “metformin with Diane 35 oral intake.” NCT03151005 ↗ |